Stroke and Stroke Care in China Huge Burden, Significant Workload, and a National Priority

被引：786

作者：

Liu, Liping ^{[1
]}

Wang, David ^{[2
,3
]}

Wong, K. S. Lawrence ^{[4
]}

Wang, Yongjun ^{[1
]}

机构：

[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China

[2] Univ Illinois, Coll Med, OSF Healthcare Syst, Dept Neurol, Peoria, IL 61656 USA

[3] Univ Illinois, Coll Med, INI Stroke Network, Peoria, IL 61656 USA

[4] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China

来源：

STROKE | 2011年 / 42卷 / 12期

关键词：

cerebrovascular disease; economics; risk factors; stroke care; ISCHEMIC-STROKE;

D O I：

10.1161/STROKEAHA.111.635755

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

At the same time as the world recognizes the rapid economic development in China, Chinese healthcare system has also had significant improvement. However, this nation of 1.4 billion faces tough challenges in treating stroke, the leading cause of death in China. The recently completed Chinese National Stroke Registry has provided new information on the status of stroke epidemiology, diagnosis, management, and prevention strategies in China. In this article, we summarized these new findings, described the effort of providing and improving stroke care, and illustrated the challenges in risk factor modification and secondary stroke prevention. Well-designed epidemiological surveys and clinical trials for stroke prevention and management are still urgently needed in China. (Stroke. 2011; 42: 3651-3654.)

引用

页码：3651 / 3654

页数：4

共 14 条

[1]

[Anonymous], 2008, 3 NATL SURVEY CAUSE

[2]

Hu XL, 2003, CHINA HEALTHCARE EC, V22, P18

[3] Stroke in China [J].

Jia, Qian ;

Liu, Li-Ping ;

Wang, Yong-Jun .

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (02) :259-264

[4] Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling [J].

Johnston, S. Claiborne ;

Mendis, Shanthi ;

Mathers, Colin D. .

LANCET NEUROLOGY, 2009, 8 (04) :345-354

[5] Stroke in China: epidemiology, prevention, and management strategies [J].

Liu, Ming ;

Wu, Bo ;

Wang, Wen-Zhi ;

Lee, Li-Ming ;

Zhang, Shi-Hong ;

Kong, Ling-Zhi .

LANCET NEUROLOGY, 2007, 6 (05) :456-464

[6]

Ministry of Health PRC, 2010, 2010 ANN CHIN HEALTH

[7] Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study [J].

O'Donnell, Martin J. ;

Xavier, Denis ;

Liu, Lisheng ;

Zhang, Hongye ;

Chin, Siu Lim ;

Rao-Melacini, Purnima ;

Rangarajan, Sumathy ;

Islam, Shofiqul ;

Pais, Prem ;

McQueen, Matthew J. ;

Mondo, Charles ;

Damasceno, Albertino ;

Lopez-Jaramillo, Patricio ;

Hankey, Graeme J. ;

Dans, Antonio L. ;

Yusoff, Khalid ;

Truelsen, Thomas ;

Diener, Hans-Christoph ;

Sacco, Ralph L. ;

Ryglewicz, Danuta ;

Czlonkowska, Anna ;

Weimar, Christian ;

Wang, Xingyu ;

Yusuf, Salim .

LANCET, 2010, 376 (9735) :112-123

[8] Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: A consecutive cross-sectional survey [J].

Wang, Yi-Long ;

Wu, Di ;

Nguyen-Huynh, Mai N. ;

Zhou, Yong ;

Wang, Chun-Xue ;

Zhao, Xing-Quan ;

Liao, Xiao-Ling ;

Liu, Li-Ping ;

Wang, Yong-Jun .

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (08) :775-781

[9] Using Recombinant Tissue Plasminogen Activator to Treat Acute Ischemic Stroke in China Analysis of the Results From the Chinese National Stroke Registry (CNSR) [J].

Wang, Yilong ;

Liao, Xiaoling ;

Zhao, Xingquan ;

Wang, David Z. ;

Wang, Chunxue ;

Nguyen-Huynh, Mai N. ;

Zhou, Yong ;

Liu, Liping ;

Wang, Xianwei ;

Liu, Gaifen ;

Li, Hao ;

Wang, Yongjun .

STROKE, 2011, 42 (06) :1658-1664

[10]

Wang YL, 2006, INT J STROKE, V2, P56

← 1 2 →